Etanercept Treatment for Children and Adolescents with Plaque Psoriasis

In this randomized trial of 211 children and adolescents with moderate-to-severe psoriasis, response rates at 12 weeks were higher among patients treated with etanercept than among those receiving placebo (57% vs. 11%, P

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2008-01, Vol.358 (3), p.241-251
Hauptverfasser:	Paller, Amy S, Siegfried, Elaine C, Langley, Richard G, Gottlieb, Alice B, Pariser, David, Landells, Ian, Hebert, Adelaide A, Eichenfield, Lawrence F, Patel, Vaishali, Creamer, Kara, Jahreis, Angelika
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Biological and medical sciences Child Child, Preschool Dermatology Double-Blind Method Drug therapy Etanercept Female General aspects Humans Immunoglobulin G - adverse effects Immunoglobulin G - therapeutic use Light therapy Male Medical sciences Pharmaceutical industry Psoriasis Psoriasis - drug therapy Psoriasis - pathology Psoriasis. Parapsoriasis. Lichen Receptors, Tumor Necrosis Factor - therapeutic use Severity of Illness Index Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	In this randomized trial of 211 children and adolescents with moderate-to-severe psoriasis, response rates at 12 weeks were higher among patients treated with etanercept than among those receiving placebo (57% vs. 11%, P
ISSN:	0028-4793 1533-4406
DOI:	10.1056/NEJMoa066886